{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:29:20Z","timestamp":1766158160417},"reference-count":94,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,4,22]]},"abstract":"<jats:sec>\n<jats:title \/>\n<jats:p>Catheter ablation for rhythm control is recommended in specific patient populations\nwith paroxysmal, persistent, or long-standing persistent atrial fibrillation. Pulmonary\nvein isolation is the cornerstone of the ablative therapy for atrial fibrillation. However, relapse\nis still common since the single procedure efficacy of atrial fibrillation ablation was estimated\nto be 60-80% in paroxysmal and 50-70% in persistent atrial fibrillation. It is important to\nidentify predictors of successful atrial fibrillation patients ablation. In the present review, we\nwill assess the role of available biomarkers to predict responders of an initial atrial fibrillation\ncatheter ablation. Emphasis has been given on the role of myocardial injury biomarkers, natriuretic\npeptides and traditional inflammatory markers. Novel inflammatory markers, oxidative\nstress biomarkers and microRNAs have also been examined as predictors of a successful atrial\nfibrillation procedure. Notably, the impact of procedural and short-term administration of\nsteroids, as well as the role of colchicine on preventing atrial fibrillation recurrence after ablation\nis thoroughly presented.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867325666180320122930","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T10:20:44Z","timestamp":1521541244000},"page":"925-937","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Biomarkers Determining Prognosis of Atrial Fibrillation Ablation"],"prefix":"10.2174","volume":"26","author":[{"given":"Dimitris","family":"Tsiachris","sequence":"first","affiliation":[{"name":"Athens Heart Center, Athens Medical Center, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Giannopoulos","sequence":"additional","affiliation":[{"name":"Athens Heart Center, Athens Medical Center, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Deftereos","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charis","family":"Kossyvakis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, 'Georgios Genimmatas' General Hospital of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christodoulos","family":"Stefanadis","sequence":"additional","affiliation":[{"name":"Athens Heart Center, Athens Medical Center, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","volume":"82","author":"Kannel W.B.","year":"1998","unstructured":"Kannel WB, Wolf PA, Benjamin EJ, Levy D.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.","journal-title":"Am J Cardiol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"Benjamin E.J.","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D\u2019Agostino RB, Silbershatz H, Kannel WB, Levy D.  Impact of atrial fibrillation on the risk of death: The Framingham heart study.","journal-title":"Circulation"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"Wang T.J.","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D\u2019Agostino RB, Murabito JM, Kannel WB, Benjamin EJ.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham heart study.","journal-title":"Circulation"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.hrthm.2011.12.016","volume":"9","author":"Calkins H.","year":"2012","unstructured":"Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D.  2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS).","journal-title":"Heart Rhythm"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/clc.22653","volume":"40","author":"Georgiopoulos G.","year":"2017","unstructured":"Georgiopoulos G, Tsiachris D, Manolis AS.  Cryoballoon ablation of atrial fibrillation: A practical and effective approach.","journal-title":"Clin Cardiol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"Ha\u00efssaguerre M.","year":"1998","unstructured":"Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le M\u00e9tayer P, Cl\u00e9menty J.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.","journal-title":"N Engl J Med"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"Verma A.","year":"2015","unstructured":"Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P.  Approaches to catheter ablation for persistent atrial fibrillation.","journal-title":"N Engl J Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.hrthm.2015.12.028","volume":"13","author":"Gianni C.","year":"2016","unstructured":"Gianni C, Mohanty S, Di Biase L, Metz T, Trivedi C, G\u00f6ko\u011flan Y, G\u00fcne\u015f MF, Bai R, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Horton RP, Hranitzky PM, Sanchez JE, Halbfa\u00df P, M\u00fcller P, Schade A, Deneke T, Tomassoni GF, Natale A.  Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation.","journal-title":"Heart Rhythm"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/jce.12474","volume":"25","author":"Miller J.M.","year":"2014","unstructured":"Miller JM, Kowal RC, Swarup V, Daubert JP, Daoud EG, Day JD, Ellenbogen KA, Hummel JD, Baykaner T, Krummen DE, Narayan SM, Reddy VY, Shivkumar K, Steinberg JS, Wheelan KR.  Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/eurheartj\/ehu291","volume":"35","author":"Haegeli L.M.","year":"2014","unstructured":"Haegeli LM, Calkins H.  Catheter ablation of atrial fibrillation: An update.","journal-title":"Eur Heart J"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/europace\/eur398","volume":"14","author":"Goudis C.A.","year":"2012","unstructured":"Goudis CA, Kallergis EM, Vardas PE.  Extracellular matrix alterations in the atria: Insights into the mechanisms and perpetuation of atrial fibrillation.","journal-title":"Europace"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0002-8703(98)70148-6","volume":"136","author":"Madrid A.H.","year":"1998","unstructured":"Madrid AH, del Rey JM, Rub\u00ed J, Ortega J, Gonz\u00e1lez Rebollo JM, Seara JG, Ripoll E, Moro C.  Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: Approach to size of necrosis.","journal-title":"Am Heart J"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1515\/CCLM.2008.341","volume":"46","author":"Pudil R.","year":"2008","unstructured":"Pudil R, Par\u00edzek P, Tich\u00fd M, Haman L, Hor\u00e1kov\u00e1 L, Ulrychov\u00e1 M, Voj\u00e1cek J, Palicka V.  Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation.","journal-title":"Clin Chem Lab Med"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ahj.2007.10.016","volume":"155","author":"Wu A.H.B.","year":"2008","unstructured":"Wu AHB, Jaffe AS.  The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing.","journal-title":"Am Heart J"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1258\/acb.2010.009280","volume":"48","author":"Vasatova M.","year":"2011","unstructured":"Vasatova M, Pudil R, Tichy M, Buchler T, Horacek JM, Haman L, Parizek P, Palicka V.  High-sensitivity troponin T as a marker of myocardial injury after radiofrequency catheter ablation.","journal-title":"Ann Clin Biochem"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1054-8807(02)00188-6","volume":"12","author":"Fishbein M.C.","year":"2003","unstructured":"Fishbein MC, Wang T, Matijasevic M, Hong L, Apple FS.  Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia.","journal-title":"Cardiovasc Pathol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1540-8159.2009.02370.x","volume":"32","author":"Alaiti M.A.","year":"2009","unstructured":"Alaiti MA, Maroo A, Edel TB.  Troponin levels after cardiac electrophysiology procedures: Review of the literature.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=18","first-page":"549","volume":"70","author":"W\u00f3jcik M.","year":"2012","unstructured":"W\u00f3jcik M, Kuniss M, Berkowitsch A, Zaltsberg S, Janin S, Wysoki\u0144ski A, Hamm CW, Pitschner HF, Neumann T.  Major determinants of myocardial injury after pulmonary vein isolation with radiofrequency ablation.","journal-title":"Kardiol Pol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.hrthm.2014.04.015","volume":"11","author":"Yoshida K.","year":"2014","unstructured":"Yoshida K, Yui Y, Kimata A, Koda N, Kato J, Baba M, Misaki M, Abe D, Tokunaga C, Akishima S, Sekiguchi Y, Tada H, Aonuma K, Takeyasu N.  Troponin elevation after radiofrequency catheter ablation of atrial fibrillation: relevance to AF substrate, procedural outcomes, and reverse structural remodeling.","journal-title":"Heart Rhythm"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCEP.113.000876","volume":"7","author":"Lim H.S.","year":"2014","unstructured":"Lim HS, Schultz C, Dang J, Alasady M, Lau DH, Brooks AG, Wong CX, Roberts-Thomson KC, Young GD, Worthley MI, Sanders P, Willoughby SR.  Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5603\/CJ.a2013.0153","volume":"21","author":"Casella M.","year":"2014","unstructured":"Casella M, Dello Russo A, Russo E, Al-Mohani G, Santangeli P, Riva S, Fassini G, Moltrasio M, Innocenti E, Colombo D, Bologna F, Izzo G, Gallinghouse JG, Di Biase L, Natale A, Tondo C.  Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablation.","journal-title":"Cardiol J"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-011-0383-3","volume":"101","author":"Richter B.","year":"2012","unstructured":"Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, Bergler-Klein J, Binder T, Wojta J, G\u00f6ssinger HD.  Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation.","journal-title":"Clin Res Cardiol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/CIRCEP.111.966523","volume":"5","author":"Arujuna A.","year":"2012","unstructured":"Arujuna A, Karim R, Caulfield D, Knowles B, Rhode K, Schaeffter T, Kato B, Rinaldi CA, Cooklin M, Razavi R, O\u2019Neill MD, Gill J.  Acute pulmonary vein isolation is achieved by a combination of reversible and irreversible atrial injury after catheter ablation: evidence from magnetic resonance imaging.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1540-8175.2001.00503.x","volume":"18","author":"Ren J.F.","year":"2001","unstructured":"Ren JF, Callans DJ, Schwartzman D, Michele JJ, Marchlinski FE.  Changes in local wall thickness correlate with pathologic lesion size following radiofrequency catheter ablation: An intracardiac echocardiographic imaging study.","journal-title":"Echocardiography"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCEP.113.000374","volume":"6","author":"Neuzil P.","year":"2013","unstructured":"Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, Lambert H, Yulzari A, Wissner E, Kuck KH.  Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jce.12618","volume":"26","author":"Wynn G.J.","year":"2015","unstructured":"Wynn GJ, Das M, Bonnett LJ, Hall MCS, Snowdon RL, Waktare JEP, Modi S, Todd DM, Gupta D.  A novel marker to predict early recurrence after atrial fibrillation ablation: The ablation effectiveness quotient.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.0000058706.82623.A1","volume":"107","author":"Khairy P.","year":"2003","unstructured":"Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, Sirois MG, Santoianni D, Dubuc M.  Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation.","journal-title":"Circulation"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.hrthm.2010.08.028","volume":"7","author":"K\u00fchne M.","year":"2010","unstructured":"K\u00fchne M, Suter Y, Altmann D, Ammann P, Schaer B, Osswald S, Sticherling C.  Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns.","journal-title":"Heart Rhythm"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.hrthm.2011.09.017","volume":"9","author":"Herrera Sikl\u00f3dy C.","year":"2012","unstructured":"Herrera Sikl\u00f3dy C, Arentz T, Minners J, Jesel L, Stratz C, Valina CM, Weber R, Kalusche D, Toti F, Morel O, Trenk D.  Cellular damage, platelet activation, and inflammatory response after pulmonary vein isolation: a randomized study comparing radiofrequency ablation with cryoablation.","journal-title":"Heart Rhythm"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2010.12.084","volume":"158","author":"Schmidt M.","year":"2012","unstructured":"Schmidt M, Marschang H, Clifford S, Harald R, Guido R, Oliver T, Johannes B, Daccarett M.  Trends in inflammatory biomarkers during atrial fibrillation ablation across different catheter ablation strategies.","journal-title":"Int J Cardiol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jce.12157","volume":"24","author":"Coulombe N.","year":"2013","unstructured":"Coulombe N, Paulin J, Su W.  Improved  performance of second-generation cryoballoon for pulmonary vein isolation.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/europace\/eut400","volume":"16","author":"Bordignon S.","year":"2014","unstructured":"Bordignon S, F\u00fcrnkranz A, Dugo D, Perrotta L, Gunawardene M, Bode F, Klemt A, Nowak B, Schulte-Hahn B, Schmidt B, Chun KR.  Improved lesion formation using the novel 28 mm cryoballoon in atrial fibrillation ablation: Analysis of biomarker release.","journal-title":"Europace"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1253\/circj.CJ-15-1051","volume":"80","author":"Miyazaki S.","year":"2016","unstructured":"Miyazaki S, Kuroi A, Hachiya H, Nakamura H, Taniguchi H, Ichihara N, Takagi T, Iwasawa J, Iesaka Y.  Early recurrence after pulmonary vein isolation of paroxysmal atrial fibrillation with different ablation technologies - Prospective comparison of radiofrequency vs. second-generation cryoballoon ablation.","journal-title":"Circ J"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5603\/KP.a2016.0089","volume":"75","author":"K\u0131z\u0131l\u0131rmak F.","year":"2017","unstructured":"K\u0131z\u0131l\u0131rmak F, Gokdeniz T, Gunes HM, Demir GG, Cakal B, Guler GB, Guler E, Olgun FE, Kilicaslan F.  Myocardial injury biomarkers after radiofrequency catheter and cryoballoon ablation for atrial fibrillation and their impact on recurrence.","journal-title":"Kardiol Pol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5830\/CVJA-2015-027","volume":"26","author":"Aksu T.","year":"2015","unstructured":"Aksu T, Golcuk SE, Guler TE, Yalin K, Erden I.  Prediction of mid-term outcome after cryo-balloon ablation of atrial fibrillation using post-procedure high-sensitivity troponin level.","journal-title":"Cardiovasc J Afr"},{"key":"ref=36","first-page":"H1684","volume":"274","author":"Luchner A.","year":"1998","unstructured":"Luchner A, Stevens TL, Borgeson DD, Redfield M, Wei CM, Porter JG, Burnett JC.  Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.","journal-title":"Am J Physiol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","volume":"350","author":"Wang T.J.","year":"2004","unstructured":"Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death.","journal-title":"N Engl J Med"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1568026611313020002","volume":"13","author":"Panagopoulou V.","year":"2013","unstructured":"Panagopoulou V, Deftereos S, Kossyvakis C, Raisakis K, Giannopoulos G, Bouras G, Pyrgakis V, Cleman MW.  NTproBNP: An important biomarker in cardiac diseases.","journal-title":"Curr Top Med Chem"},{"key":"ref=39","first-page":"265","volume":"47","author":"Hammerer-Lercher A.","year":"2001","unstructured":"Hammerer-Lercher A, Puschendorf B, Mair J.  Cardiac natriuretic peptides: New laboratory parameters in heart failure patients.","journal-title":"Clin Lab"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1161\/CIRCULATIONAHA.110.007252","volume":"123","author":"Hussein A.A.","year":"2011","unstructured":"Hussein AA, Saliba WI, Martin DO, Shadman M, Kanj M, Bhargava M, Dresing T, Chung M, Callahan T, Baranowski B, Tchou P, Lindsay BD, Natale A, Wazni OM.  Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation.","journal-title":"Circulation"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10840-014-9898-7","volume":"40","author":"Pillarisetti J.","year":"2014","unstructured":"Pillarisetti J, Reddy N, Biria M, Ryschon K, Nagarajan D, Murray C, Atkins D, Bommana S, Reddy MY, DiBiase L, Pimentel R, Berenbom L, Dawn B, Natale A, Lakkireddy D.  Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?","journal-title":"J Interv Card Electrophysiol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/hrt.2005.083022","volume":"92","author":"Date T.","year":"2006","unstructured":"Date T, Yamane T, Inada K, Matsuo S, Miyanaga S, Sugimoto K, Shibayama K, Taniguchi I, Mochizuki S.  Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation.","journal-title":"Heart"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ahj.2010.09.031","volume":"161","author":"den Uijl D.W.","year":"2011","unstructured":"den Uijl DW, Delgado V, Tops LF, Ng AC, Boersma E, Trines SA, Zeppenfeld K, Schalij MJ, van der Laarse A, Bax JJ.  Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation.","journal-title":"Am Heart J"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10840-011-9606-9","volume":"33","author":"Fan J.","year":"2012","unstructured":"Fan J, Cao H, Su L, Ling Z, Liu Z, Lan X, Xu Y, Chen W, Yin Y.  NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.","journal-title":"J Interv Card Electrophysiol"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00392-009-0744-3","volume":"98","author":"Hwang H.J.","year":"2009","unstructured":"Hwang HJ, Son JW, Nam BH, Joung B, Lee B, Kim JB, Lee MH, Jang Y, Chung N, Shim WH, Cho SY, Kim SS.  Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.","journal-title":"Clin Res Cardiol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.hrthm.2015.04.002","volume":"12","author":"Giannopoulos G.","year":"2015","unstructured":"Giannopoulos G, Kossyvakis C, Angelidis C, Efremidis M, Panagopoulou V, Letsas K, Bouras G, Vassilikos VP, Goudevenos J, Tousoulis D, Lekakis J, Deftereos S.  Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.","journal-title":"Heart Rhythm"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2004.09.045","volume":"45","author":"Ellinor P.T.","year":"2005","unstructured":"Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA.  Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation.","journal-title":"J Am Coll Cardiol"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/hrt.2009.190314","volume":"96","author":"Deftereos S.","year":"2010","unstructured":"Deftereos S, Giannopoulos G, Kossyvakis C, Raisakis K, Theodorakis A, Kaoukis A, Toli K, Panagopoulou V, Driva M, Mantas I, Pyrgakis V, Alpert MA.  Short-term fluctuations of plasma NT-proBNP levels in patients with new-onset atrial fibrillation: a way to assess time of onset?","journal-title":"Heart"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/hrt.2010.214742","volume":"97","author":"Deftereos S.","year":"2011","unstructured":"Deftereos S, Giannopoulos G, Kossyvakis C, Raisakis K, Kaoukis A, Aggeli C, Toli K, Theodorakis A, Panagopoulou V, Driva M, Mantas I, Pyrgakis V, Rentoukas I, Stefanadis C.  Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset.","journal-title":"Heart"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1536\/ihj.15-355","volume":"57","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y, Chen A, Song L, Li M, Chen Y, He B.  Association between baseline natriuretic peptides and atrial fibrillation recurrence after catheter ablation.","journal-title":"Int Heart J"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","volume":"50","author":"Issac T.T.","year":"2007","unstructured":"Issac TT, Dokainish H, Lakkis NM.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.","journal-title":"J Am Coll Cardiol"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","volume":"108","author":"Aviles R.J.","year":"2003","unstructured":"Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK.  Inflammation as a risk factor for atrial fibrillation.","journal-title":"Circulation"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/europace\/eum072","volume":"9","author":"Tziakas D.N.","year":"2007","unstructured":"Tziakas DN, Chalikias GK, Papanas N, Stakos DA, Chatzikyriakou SV, Maltezos E.  Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation.","journal-title":"Europace"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/14017430802653676","volume":"43","author":"Henningsen K.M.","year":"2009","unstructured":"Henningsen KM, Nilsson B, Bruunsgaard H, Chen X, Pedersen BK, Svendsen JH.  Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation.","journal-title":"Scand Cardiovasc J"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/europace\/euq439","volume":"13","author":"Yamashita T.","year":"2011","unstructured":"Yamashita T, Inoue H, Okumura K, Kodama I, Aizawa Y, Atarashi H, Ohe T, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Koretsune Y, Saikawa T, Sakurai M, Sato T, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E, Ogawa S.  Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).","journal-title":"Europace"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1540-8167.2010.01925.x","volume":"22","author":"Negi S.","year":"2011","unstructured":"Negi S, Shukrullah I, Veledar E, Bloom HL, Jones DP, Dudley SC.  Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial).","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.amjcard.2009.10.019","volume":"105","author":"Lin Y.J.","year":"2010","unstructured":"Lin YJ, Tsao HM, Chang SL, Lo LW, Tuan TC, Hu YF, Udyavar AR, Tsai WC, Chang CJ, Tai CT, Lee PC, Suenari K, Huang SY, Nguyen HT, Chen SA.  Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation.","journal-title":"Am J Cardiol"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2005.12.038","volume":"47","author":"Rotter M.","year":"2006","unstructured":"Rotter M, Ja\u00efs P, Vergnes MC, Nurden P, Takahashi Y, Sanders P, Rostock T, Hocini M, Sacher F, Ha\u00efssaguerre M.  Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation.","journal-title":"J Am Coll Cardiol"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1540-8159.2008.01155.x","volume":"31","author":"McCabe J.M.","year":"2008","unstructured":"McCabe JM, Smith LM, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE, Marcus GM.  Protracted CRP elevation after atrial fibrillation ablation.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/europace\/eup077","volume":"11","author":"Lellouche N.","year":"2009","unstructured":"Lellouche N, Sacher F, Wright M, Nault I, Brottier J, Knecht S, Matsuo S, Lomas O, Hocini M, Ha\u00efssaguerre M, Ja\u00efs P.  Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation.","journal-title":"Europace"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.amjcard.2009.01.010","volume":"103","author":"Koyama T.","year":"2009","unstructured":"Koyama T, Sekiguchi Y, Tada H, Arimoto T, Yamasaki H, Kuroki K, Machino T, Tajiri K, Zhu XD, Kanemoto M, Sugiyasu A, Kuga K, Aonuma K.  Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation.","journal-title":"Am J Cardiol"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1540-8167.1999.tb00680.x","volume":"10","author":"Grubman E.","year":"1999","unstructured":"Grubman E, Pavri BB, Lyle S, Reynolds C, Denofrio D, Kocovic DZ.  Histopathologic effects of radiofrequency catheter ablation in previously infarcted human myocardium.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1540-8167.1998.tb00883.x","volume":"9","author":"Rodriguez L.M.","year":"1998","unstructured":"Rodriguez LM, Leunissen J, Hoekstra A, Korteling BJ, Smeets JL, Timmermans C, Vos M, Daemen M, Wellens HJ.  Transvenous cold mapping and cryoablation of the AV node in dogs: observations of chronic lesions and comparison to those obtained using radiofrequency ablation.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/eurheartj\/ehi255","volume":"26","author":"Deneke T.","year":"2005","unstructured":"Deneke T, Khargi K, M\u00fcller KM, Lemke B, M\u00fcgge A, Laczkovics A, Becker AE, Grewe PH.  Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation.","journal-title":"Eur Heart J"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1540-8159.1999.tb00353.x","volume":"22","author":"Dubuc M.","year":"1999","unstructured":"Dubuc M, Roy D, Thibault B, Ducharme A, Tardif JC, Villemaire C, Leung TK, Talajic M.  Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.hlc.2014.02.003","volume":"23","author":"Kimura T.","year":"2014","unstructured":"Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T, Nishiyama N, Fukumoto K, Aizawa Y, Tanimoto Y, Tanimoto K, Fukuda K.  Serum inflammation markers predicting successful initial catheter ablation for atrial fibrillation.","journal-title":"Heart Lung Circ"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2261-11-77","volume":"11","author":"Kalogeropoulos A.S.","year":"2011","unstructured":"Kalogeropoulos AS, Tsiodras S, Rigopoulos AG, Sakadakis EA, Triantafyllis A, Kremastinos DT, Rizos I.  Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=68","first-page":"1160","volume":"30","author":"Wang W.","year":"2010","unstructured":"Wang W, Wu PS, Yang XL.  Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/europace\/eun389","volume":"11","author":"Kato K.","year":"2009","unstructured":"Kato K, Fujimaki T, Yoshida T, Oguri M, Yajima K, Hibino T, Murohara T.  Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation.","journal-title":"Europace"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1540-8167.2011.02059.x","volume":"22","author":"Okumura Y.","year":"2011","unstructured":"Okumura Y, Watanabe I, Nakai T, Ohkubo K, Kofune T, Kofune M, Nagashima K, Mano H, Sonoda K, Kasamaki Y, Hirayama A.  Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: Importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=71","first-page":"1976","volume":"124","author":"Deng H.","year":"2011","unstructured":"Deng H, Xue YM, Zhan XZ, Liao HT, Guo HM, Wu SL.  Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation.","journal-title":"Chin Med J (Engl)"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.0000165119.62099.14","volume":"111","author":"Ueland T.","year":"2005","unstructured":"Ueland T, Yndestad A, \u00d8ie E, Florholmen G, Halvorsen B, Fr\u00f8land SS, Simonsen S, Christensen G, Gullestad L, Aukrust P.  Dysregulated osteoprotegerin\/RANK ligand\/RANK axis in clinical and experimental heart failure.","journal-title":"Circulation"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2009.02.053","volume":"104","author":"Schnabel R.B.","year":"2009","unstructured":"Schnabel RB, Larson MG, Yamamoto JF, Kathiresan S, Rong J, Levy D, Keaney JF, Wang TJ, Vasan RS, Benjamin EJ.  Relation of multiple inflammatory biomarkers to incident atrial fibrillation.","journal-title":"Am J Cardiol"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1253\/circj.CJ-11-0795","volume":"75","author":"Cao H.","year":"2011","unstructured":"Cao H, Wang J, Xi L, R\u00f8e OD, Chen Y, Wang D.  Dysregulated atrial gene expression of osteoprotegerin\/receptor activator of nuclear factor-\u03baB (RANK)\/RANK ligand axis in the development and progression of atrial fibrillation.","journal-title":"Circ J"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijcard.2013.08.084","volume":"170","author":"Cao H.","year":"2014","unstructured":"Cao H, Wu Y, Li Q, Wu Y, Zhou Q, R\u00f8e OD, Chen Y, Wang R, Wang D.  Serum sRANKL\/OPG predict recurrence after radiofrequency catheter ablation of lone atrial fibrillation.","journal-title":"Int J Cardiol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2006.04.026","volume":"115","author":"Korantzopoulos P.","year":"2007","unstructured":"Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA.  The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.","journal-title":"Int J Cardiol"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.CIR.104.2.174","volume":"104","author":"Mihm M.J.","year":"2001","unstructured":"Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA.  Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation.","journal-title":"Circulation"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/emm.2003.45","volume":"35","author":"Kim Y.H.","year":"2003","unstructured":"Kim YH, Lim DS, Lee JH, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK.  Gene expression profiling of oxidative stress on atrial fibrillation in humans.","journal-title":"Exp Mol Med"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jelectrocard.2016.03.007","volume":"49","author":"B\u00f6hm A.","year":"2016","unstructured":"B\u00f6hm A, Tothova L, Urban L, Slezak P, Bacharova L, Musil P, Hatala R.  The relation between oxidative stress biomarkers and atrial fibrillation after pulmonary veins isolation.","journal-title":"J Electrocardiol"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"e73397","DOI":"10.1371\/journal.pone.0073397","volume":"8","author":"Nishi H.","year":"2013","unstructured":"Nishi H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S, Ueno T, Kuratani T, Sawa Y.  Impact of microRNA expression in human atrial tissue in patients with atrial fibrillation undergoing cardiac surgery.","journal-title":"PLoS One"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/CIRCULATIONAHA.112.001207","volume":"127","author":"Dawson K.","year":"2013","unstructured":"Dawson K, Wakili R, Ordog B, Clauss S, Chen Y, Iwasaki Y.  MicroRNA29: A mechanistic contributor and potential biomarker in atrial fibrillation.","journal-title":"Circulation"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/europace\/euu366","volume":"18","author":"Liu T.","year":"2016","unstructured":"Liu T, Zhong S, Rao F, Xue Y, Qi Z, Wu S.  Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients.","journal-title":"Europace"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.amjcard.2015.09.028","volume":"116","author":"Sousa P.A.","year":"2015","unstructured":"Sousa PA, Provid\u00eancia R, Albenque JP, Khoueiry Z, Combes N, Combes S, Boveda S.  Impact of free thyroxine on the outcomes of left atrial ablation procedures.","journal-title":"Am J Cardiol"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1253\/circj.CJ-12-0340","volume":"76","author":"Machino T.","year":"2012","unstructured":"Machino T, Tada H, Sekiguchi Y, Yamasaki H, Kuroki K, Igarashi M, Naruse Y, Nakano E, Ito Y, Kaneshiro T, Yoshida K, Aonuma K.  Prevalence and influence of hyperthyroidism on the long-term outcome of catheter ablation for drug-refractory atrial fibrillation.","journal-title":"Circ J"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jacc.2010.02.025","volume":"55","author":"Maisel A.","year":"2010","unstructured":"Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.  Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: Results from the BACH (Biomarkers in Acute Heart Failure) trial.","journal-title":"J Am Coll Cardiol"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijcard.2014.11.117","volume":"180","author":"Parwani A.S.","year":"2015","unstructured":"Parwani AS, von Haehling S, Kolodziejski AI, Huemer M, Wutzler A, Attanasio P, Stojakovic T, Scharnagl H, Haverkamp W, Boldt LH.  Mid-regional proadrenomedullin levels predict recurrence of atrial fibrillation after catheter ablation.","journal-title":"Int J Cardiol"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2014.02.009","volume":"167","author":"Ho J.E.","year":"2014","unstructured":"Ho JE, Yin X, Levy D, Vasan RS, Magnani JW, Ellinor PT, McManus DD, Lubitz SA, Larson MG, Benjamin EJ.  Galectin 3 and incident atrial fibrillation in the community.","journal-title":"Am Heart J"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"e0123574","DOI":"10.1371\/journal.pone.0123574","volume":"10","author":"Kornej J.","year":"2015","unstructured":"Kornej J, Schmidl J, Ueberham L, John S, Daneschnejad S, Dinov B, Hindricks G, Adams V, Husser D, Bollmann A.  Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation.","journal-title":"PLoS One"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.hrthm.2013.07.037","volume":"10","author":"Andrade J.G.","year":"2013","unstructured":"Andrade JG, Khairy P, Nattel S, Vanella A, Rivard L, Guerra PG, Dubuc M, Dyrda K, Thibault B, Talajic M, Mondesert B, Roy D, Macle L.  Corticosteroid use during pulmonary vein isolation is associated with a higher prevalence of dormant pulmonary vein conduction.","journal-title":"Heart Rhythm"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1253\/circj.CJ-12-0728","volume":"77","author":"Won H.","year":"2013","unstructured":"Won H, Kim JY, Shim J, Uhm JS, Pak HN, Lee MH, Joung B.  Effect of a single bolus injection of low-dose hydrocortisone for prevention of atrial fibrillation recurrence after radiofrequency catheter ablation.","journal-title":"Circ J"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jacc.2010.04.057","volume":"56","author":"Koyama T.","year":"2010","unstructured":"Koyama T, Tada H, Sekiguchi Y, Arimoto T, Yamasaki H, Kuroki K, Machino T, Tajiri K, Zhu XD, Kanemoto-Igarashi M, Sugiyasu A, Kuga K, Nakata Y, Aonuma K.  Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial.","journal-title":"J Am Coll Cardiol"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/CIRCEP.115.002957","volume":"8","author":"Kim Y.R.","year":"2015","unstructured":"Kim YR, Nam GB, Han S, Kim SH, Kim KH, Lee S, Kim J, Choi KJ, Kim YH.  Effect of short-term steroid therapy on early recurrence during the blanking period after catheter ablation of atrial fibrillation.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.hrthm.2014.02.002","volume":"11","author":"Deftereos S.","year":"2014","unstructured":"Deftereos S, Giannopoulos G, Efremidis M, Kossyvakis C, Katsivas A, Panagopoulou V, Papadimitriou C, Karageorgiou S, Doudoumis K, Raisakis K, Kaoukis A, Alexopoulos D, Manolis AS, Stefanadis C, Cleman MW.  Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life.","journal-title":"Heart Rhythm"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2012.07.031","volume":"60","author":"Deftereos S.","year":"2012","unstructured":"Deftereos S, Giannopoulos G, Kossyvakis C, Efremidis M, Panagopoulou V, Kaoukis A, Raisakis K, Bouras G, Angelidis C, Theodorakis A, Driva M, Doudoumis K, Pyrgakis V, Stefanadis C.  Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: A randomized controlled study.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/160579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T13:43:25Z","timestamp":1558359805000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/160579\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,4,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180320122930","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2016-11-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}